Criptococosis cerebral, voriconazol, niveles plasmáticos y síndrome de reconstitución inmune. Reporte de un caso

We report a 45-year-old male with AIDS who had a Cryptococcus neoformans central nervous system infection. He was treated with amphotericin B deoxycholate subsequently changed to voriconazole due to systemic toxicity of the former. Plasma levels of voriconazole were insufficient with a standard dose (0.7 μg/mL), therefore, the dose was increased thereafter to reach appropriate levels (4.5 μg/mL). Anti-retroviral therapy was started five weeks after voriconazole initiation with non-interacting drugs and he was discharged after a favorable evolution. He was re-admitted three months later due to seizures; a brain magnetic resonance showed new sub-cortical nodules. After excluding alternative causes and demonstrating fungal eradication, an immune reconstitution inflammatory syndrome (IRIS) event was suspected and treated with a short course of steroids. His evolution was satisfactory.

Saved in:
Bibliographic Details
Main Authors: Téllez R.,María, Salgueiro C.,Catalina, Leiva Hernández,Marcelo, Fica,Alberto
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2018
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018001201481
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-98872018001201481
record_format ojs
spelling oai:scielo:S0034-988720180012014812019-02-18Criptococosis cerebral, voriconazol, niveles plasmáticos y síndrome de reconstitución inmune. Reporte de un casoTéllez R.,MaríaSalgueiro C.,CatalinaLeiva Hernández,MarceloFica,Alberto Acquired Immunodeficiency Syndrome Drug monitoring Immune Reconstitution Inflammatory Syndrome Meningitis, Cryptococcal Voriconazole We report a 45-year-old male with AIDS who had a Cryptococcus neoformans central nervous system infection. He was treated with amphotericin B deoxycholate subsequently changed to voriconazole due to systemic toxicity of the former. Plasma levels of voriconazole were insufficient with a standard dose (0.7 μg/mL), therefore, the dose was increased thereafter to reach appropriate levels (4.5 μg/mL). Anti-retroviral therapy was started five weeks after voriconazole initiation with non-interacting drugs and he was discharged after a favorable evolution. He was re-admitted three months later due to seizures; a brain magnetic resonance showed new sub-cortical nodules. After excluding alternative causes and demonstrating fungal eradication, an immune reconstitution inflammatory syndrome (IRIS) event was suspected and treated with a short course of steroids. His evolution was satisfactory.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.146 n.12 20182018-12-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018001201481es10.4067/s0034-98872018001201481
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language Spanish / Castilian
format Digital
author Téllez R.,María
Salgueiro C.,Catalina
Leiva Hernández,Marcelo
Fica,Alberto
spellingShingle Téllez R.,María
Salgueiro C.,Catalina
Leiva Hernández,Marcelo
Fica,Alberto
Criptococosis cerebral, voriconazol, niveles plasmáticos y síndrome de reconstitución inmune. Reporte de un caso
author_facet Téllez R.,María
Salgueiro C.,Catalina
Leiva Hernández,Marcelo
Fica,Alberto
author_sort Téllez R.,María
title Criptococosis cerebral, voriconazol, niveles plasmáticos y síndrome de reconstitución inmune. Reporte de un caso
title_short Criptococosis cerebral, voriconazol, niveles plasmáticos y síndrome de reconstitución inmune. Reporte de un caso
title_full Criptococosis cerebral, voriconazol, niveles plasmáticos y síndrome de reconstitución inmune. Reporte de un caso
title_fullStr Criptococosis cerebral, voriconazol, niveles plasmáticos y síndrome de reconstitución inmune. Reporte de un caso
title_full_unstemmed Criptococosis cerebral, voriconazol, niveles plasmáticos y síndrome de reconstitución inmune. Reporte de un caso
title_sort criptococosis cerebral, voriconazol, niveles plasmáticos y síndrome de reconstitución inmune. reporte de un caso
description We report a 45-year-old male with AIDS who had a Cryptococcus neoformans central nervous system infection. He was treated with amphotericin B deoxycholate subsequently changed to voriconazole due to systemic toxicity of the former. Plasma levels of voriconazole were insufficient with a standard dose (0.7 μg/mL), therefore, the dose was increased thereafter to reach appropriate levels (4.5 μg/mL). Anti-retroviral therapy was started five weeks after voriconazole initiation with non-interacting drugs and he was discharged after a favorable evolution. He was re-admitted three months later due to seizures; a brain magnetic resonance showed new sub-cortical nodules. After excluding alternative causes and demonstrating fungal eradication, an immune reconstitution inflammatory syndrome (IRIS) event was suspected and treated with a short course of steroids. His evolution was satisfactory.
publisher Sociedad Médica de Santiago
publishDate 2018
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018001201481
work_keys_str_mv AT tellezrmaria criptococosiscerebralvoriconazolnivelesplasmaticosysindromedereconstitucioninmunereportedeuncaso
AT salgueiroccatalina criptococosiscerebralvoriconazolnivelesplasmaticosysindromedereconstitucioninmunereportedeuncaso
AT leivahernandezmarcelo criptococosiscerebralvoriconazolnivelesplasmaticosysindromedereconstitucioninmunereportedeuncaso
AT ficaalberto criptococosiscerebralvoriconazolnivelesplasmaticosysindromedereconstitucioninmunereportedeuncaso
_version_ 1755988604632432640